IntegraGen to attend 36th Annual JP Morgan Healthcare Conference

IntegraGen will be in attendance at 36th Annual JP Morgan Healthcare Conference being held in San Francisco on January 8 – 11, 2018. The J.P. Morgan Healthcare Conference is the largest and most informative healthcare investment symposium in the industry which brings together global industry leaders, emerging fast-growth (…)  » 

IntegraGen to attend 35th Annual JP Morgan Healthcare Conference

IntegraGen  will be in attendance at 35th Annual JP Morgan Healthcare Conference being held in San Francisco on January 9-12, 2017. The J.P. Morgan Healthcare Conference is the largest and most informative healthcare investment symposium in the industry which brings together global industry leaders, emerging fast-growth companies, innovative (…)  » 

IntegraGen’s Scientific Advisory Board Meets to Review latest miR-31-3p data

IntegraGen’s oncology Scientific Advisory Board (SAB) recently met at the venue of the 2016 American Society of Oncology’s (ASCO) Gastrointestinal Cancers Symposium in San Francisco to review the results from the latest clinical study exploring the predictivity of miR-31-3p on the efficacy of anti-EGFR therapy in all-RAS wild-type metastatic colorectal cancer (…)  »